RSHU.F Stock Overview
An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Respiri Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.058 |
| 52 Week High | AU$0.058 |
| 52 Week Low | AU$0.0015 |
| Beta | -0.17 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | 35.12% |
| Change since IPO | 205.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSHU.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 6.4% | -0.4% | -1.0% |
| 1Y | n/a | 20.3% | 30.3% |
Return vs Industry: Insufficient data to determine how RSHU.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how RSHU.F performed against the US Market.
Price Volatility
| RSHU.F volatility | |
|---|---|
| RSHU.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RSHU.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine RSHU.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Marjan Mikel | respiri.co |
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal.
Respiri Limited Fundamentals Summary
| RSHU.F fundamental statistics | |
|---|---|
| Market cap | US$68.93m |
| Earnings (TTM) | -US$4.64m |
| Revenue (TTM) | US$676.25k |
99.4x
P/S Ratio-14.5x
P/E RatioIs RSHU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSHU.F income statement (TTM) | |
|---|---|
| Revenue | AU$1.04m |
| Cost of Revenue | AU$3.86k |
| Gross Profit | AU$1.03m |
| Other Expenses | AU$8.16m |
| Earnings | -AU$7.13m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0055 |
| Gross Margin | 99.63% |
| Net Profit Margin | -686.48% |
| Debt/Equity Ratio | 41.7% |
How did RSHU.F perform over the long term?
See historical performance and comparison